))
S4 E2 - Elizabeth Griffiths, MD – Real World Evidence in Myelodysplastic Syndromes
Manage episode 407348218 series 3559566
Контент предоставлен Karger Publishers. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Karger Publishers или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
This is the second episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management.
In this episode, Dr. Griffiths discusses what makes Real World Evidence and how it is obtained or archived, the risk stratification of MDS and what that means for gathering evidence, and bridging the gap between the best outcomes of clinical trials and the down-to-Earth results seen in daily clinical practice.
For more podcast episodes from Karger please visit karger.com/podcasts.
This podcast was funded by Taiho Oncology, Inc. The faculty and publisher are solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this site is not medical advice and does not replace independent medical judgment.
17 эпизодов
Поделиться
